Announcing the BLUE KNIGHT™ Resident QuickFire Challenge: Accelerating Project NextGen June 4, 2023 – Johnson & Johnson Innovation, together with The Biomedical Advanced Research and Development Authority (BARDA), is proud to announce [….]
Uvax Bio Preps to Take HIV Vaccine into the Clinic
Published on :Uvax Bio Preps to Take HIV Vaccine into the Clinic By Mark TerryMay 2, 2023 Uvax Bio, headquartered in Newark, Del., recently published preclinical results in Nature Communications showing the [….]
BioHealth Capital Region Forum 2022 Preview
Published on :There is no better way to get a glimpse into the future of the region’s life sciences ecosystem than the 8th annual BioHealth Capital Region (BHCR) Forum, which is fast approaching. The 2022 BHCR Forum is a can’t miss in-person/live streamed event hosted at United States Pharmacopeia (USP) in Rockville, Maryland on September 20th. Also, on September 21st at USP will be the 5th Annual BioHealth Capital Region Investment Conference and the 7th Annual Crab Trap Competition.
2021 Mid-Atlantic Science and Technology Virtual Showcase
Published on :The ISPE Chesapeake Bay Area Chapter Mid-Atlantic Science & Technology (MAST) Virtual Showcase, hosted on May 19th, 2021, provided a platform for life science companies to discuss strategies for addressing challenges in the life science industry.
BioBuzz celebrates Asian/Pacific American Heritage (AAPI) Month
Published on :Asian/Pacific American Heritage (AAPI) Month is celebrated annually during the month of May. It marks the celebration of Asians and Pacific Islanders in the United States.
Virginia Life Sciences Ecosystem Gets Boost from Essential Medicines-Focused Phlow, Civica Rx
Published on :The ongoing COVID-19 pandemic greatly exposed a dearth of essential medications and significant vulnerabilities in the United States medical supply chain. Phlow Corporation aims to mitigate those weaknesses and manufacture essential generic medications at its Virginia manufacturing facility.
The BioHealth Capital Region, Epicenter of U.S. Regulatory Infrastructure
Published on :As one of the world’s top bio hubs, the BioHealth Capital Region (BHCR) is rife with life science assets. The region has been at the forefront of the SARS-CoV-2 vaccine race and it is rapidly becoming a center for advanced manufacturing. The BHCR cell and gene therapy ecosystem is thriving, and the area boasts one of the richest and most diverse tapestries of life science talent and workforce development programming. What’s more, Maryland, Washington, DC, and Virginia are home to several dynamic university systems that keep the talent and tech transfer pipeline humming and full.
BioFactura Funded $13 Million Contract Option for its Smallpox Biodefense Therapeutic
Published on :BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, as part of BioFactura’s prime contract
Civica To Create 186 Jobs With New Virginia Pharmaceutical Facility
Published on :Pharmaceutical manufacturer Civica Inc. will invest $124.5 million to establish its first in-house pharmaceutical manufacturing operation in the City of Petersburg, VA. The project will create 186 new jobs.
5 Questions with Rachel Rath, MBA, MPH, Director, BARDA Alliance for Johnson & Johnson Innovation, JLABS @ Washington, DC
Published on :Rachel is the Director of the BARDA Alliance for Johnson & Johnson Innovation, based at JLABS @ Washington, DC. In this role, she is responsible for managing the BLUE KNIGHT™ collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA). BLUE KNIGHT™ focuses on addressing public-health threats and emerging infectious diseases by supporting companies with emerging science and technology solutions that aim to improve health security and responses.